樂觀
$56.20
情境價格
$63.520
+1.264 (+1.99%)收盤時
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.
Citi
$92
2026-08-13
Citi
2026-08-13
目標價
$92
Canaccord
$105
2026-08-07
Canaccord
2026-08-07
目標價
$105
Mizuho
$105
2026-07-15
Mizuho
2026-07-15
目標價
$105
Citi
$92
2026-07-08
Citi
2026-07-08
目標價
$92
BTIG
$90
2026-05-07
BTIG
2026-05-07
目標價
$90
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Latest Wall Street Rating Updates

Establishment Labs Receives FDA Approval for Expanded Breast Implant Range

Establishment Labs Presents New Clinical Data on Breast Tissue Preservation

GLP-1 Drugs Boost Demand for Breast Augmentation

Global Medical Aesthetics Market Poised for Significant Growth
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.
3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。